Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
30.52
+0.97 (3.28%)
At close: Jun 26, 2026, 4:00 PM EDT
30.07
-0.45 (-1.47%)
After-hours: Jun 26, 2026, 6:06 PM EDT
Sutro Biopharma Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Sutro Biopharma stock have an average target of 48.6, with a low estimate of 27 and a high estimate of 60. The average target predicts an increase of 59.24% from the current stock price of 30.52.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Sutro Biopharma stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 6 | 8 | 9 | 10 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 3 | 3 | 1 | 1 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 12 | 12 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $56 | Buy | Maintains | $56 | +83.49% | Jun 23, 2026 |
| Truist Financial | Truist Financial | Buy Initiates $50 | Buy | Initiates | $50 | +63.83% | Jun 11, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $54 | Buy | Maintains | $54 | +76.93% | May 30, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $50 | Buy | Maintains | $50 | +63.83% | May 26, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Reiterates n/a | Sell | Reiterates | n/a | n/a | May 22, 2026 |
Financial Forecast
Revenue This Year
45.06M
from 102.48M
Decreased by -56.03%
Revenue Next Year
32.22M
from 45.06M
Decreased by -28.50%
EPS This Year
-7.80
from -16.20
EPS Next Year
-6.89
from -7.80
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 69.2M | 71.3M | |
| Avg | 45.1M | 32.2M | |
| Low | 14.5M | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -32.5% | 58.2% | |
| Avg | -56.0% | -28.5% | |
| Low | -85.9% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -7.30 | -4.86 | |
| Avg | -7.80 | -6.89 | |
| Low | -8.31 | -10.31 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.